Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

OvaCheck: let's not dismiss the concept.

Villanueva J, Tempst P.

Nature. 2004 Aug 5;430(7000):611. No abstract available.

PMID:
15295571
2.

Sample collection and handling: getting accurate results.

Meinkoth JH, Allison RW.

Vet Clin North Am Small Anim Pract. 2007 Mar;37(2):203-19, v. Review.

PMID:
17336671
3.

[Diagnostic tests--use and interpretation].

Asberg A.

Tidsskr Nor Laegeforen. 1993 Feb 20;113(5):604-8. Review. Norwegian.

PMID:
8465320
4.

Ovarian cancer in the proteomics era.

Annunziata CM, Azad N, Dhamoon AS, Whiteley G, Kohn EC.

Int J Gynecol Cancer. 2008 Mar-Apr;18 Suppl 1:1-6. doi: 10.1111/j.1525-1438.2007.01096.x. Review.

PMID:
18336391
5.

[DNA microarrays and papillary thyroid carcinoma gene expression profile].

Jarzab B, Gubała E, Lange D.

Endokrynol Pol. 2005 May-Jun;56(3):293-301. Review. Polish.

PMID:
16350722
6.

Screening and detection of ovarian cancer.

Breedlove G, Busenhart C.

J Midwifery Womens Health. 2005 Jan-Feb;50(1):51-4. Review.

PMID:
15637515
7.

Biomarkers of ovarian tumours.

Rapkiewicz AV, Espina V, Petricoin EF 3rd, Liotta LA.

Eur J Cancer. 2004 Nov;40(17):2604-12. Review.

PMID:
15541961
8.

PCR-Based amplification of platelet mRNA sequences obtained from small-scale platelet samples.

Rox JM, Müller J, Pötzsch B.

Methods Mol Biol. 2009;496:285-92. doi: 10.1007/978-1-59745-553-4_18. Review.

PMID:
18839117
9.

RNA stabilization of peripheral blood and profiling by bead chip analysis.

Debey-Pascher S, Eggle D, Schultze JL.

Methods Mol Biol. 2009;496:175-210. doi: 10.1007/978-1-59745-553-4_13. Review.

PMID:
18839112
10.

[Molecular profiling and predictive signatures. Biomarker analysis in ovarian cancer].

Denkert C.

Pathologe. 2008 Nov;29 Suppl 2:168-71. doi: 10.1007/s00292-008-1073-4. Review. German.

PMID:
18931999
11.

Reproducibility of microarray studies: concordance of current analysis methods.

Wayland MT, Bahn S.

Prog Brain Res. 2006;158:109-25. Review. No abstract available.

PMID:
17027693
12.

Genome-wide platelet RNA profiling in clinical samples.

Schedel A, Rolf N.

Methods Mol Biol. 2009;496:273-83. doi: 10.1007/978-1-59745-553-4_17. Review.

PMID:
18839116
13.

Evaluation of diagnostic tests for infectious diseases: general principles.

TDR Diagnostics Evaluation Expert Panel, Banoo S, Bell D, Bossuyt P, Herring A, Mabey D, Poole F, Smith PG, Sriram N, Wongsrichanalai C, Linke R, O'Brien R, Perkins M, Cunningham J, Matsoso P, Nathanson CM, Olliaro P, Peeling RW, Ramsay A.

Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S17-29. Review. No abstract available.

PMID:
21548184
14.

Grading quality of evidence and strength of recommendations for diagnostic tests and strategies.

Horvath AR.

Clin Chem. 2009 May;55(5):853-5. doi: 10.1373/clinchem.2008.117614. Epub 2009 Mar 19. Review. No abstract available.

15.

Early diagnosis and predictors of malignancy of adnexal masses.

Murta EF, Nomelini RS.

Curr Opin Obstet Gynecol. 2006 Feb;18(1):14-9. Review.

PMID:
16493254
16.

Quality and reliability of routine coagulation testing: can we trust that sample?

Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC.

Blood Coagul Fibrinolysis. 2006 Oct;17(7):513-9. Review.

PMID:
16988544
17.

Clinical applications of expression profiling and proteomics in prostate cancer.

Masters JR.

Anticancer Res. 2007 May-Jun;27(3A):1273-6. Review.

Items per page

Supplemental Content

Write to the Help Desk